Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Jörres RA[au]:

Accuracy of FENO for diagnosing asthma: a systematic review. Karrasch S et al. Thorax. (2017)

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients. Karl FM et al. Respir Res. (2017)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency. Fähndrich S et al. Respir Res. (2017)

Search results

Items: 1 to 50 of 198

1.

Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort.

Trudzinski FC, Kahnert K, Vogelmeier CF, Alter P, Seiler F, Fähndrich S, Watz H, Welte T, Speer T, Zewinger S, Biertz F, Kauczor HU, Jörres RA, Bals R; COSYCONET consortium.

Respir Med. 2019 Jun 11;154:18-26. doi: 10.1016/j.rmed.2019.06.007. [Epub ahead of print]

PMID:
31203096
2.

Diagnostic accuracy of capnovolumetry for the identification of airway obstruction - results of a diagnostic study in ambulatory care.

Kellerer C, Jankrift N, Jörres RA, Klütsch K, Wagenpfeil S, Linde K, Schneider A.

Respir Res. 2019 May 15;20(1):92. doi: 10.1186/s12931-019-1067-1.

3.

Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD.

Alter P, Watz H, Kahnert K, Rabe KF, Biertz F, Fischer R, Jung P, Graf J, Bals R, Vogelmeier CF, Jörres RA.

Respir Res. 2019 Mar 27;20(1):61. doi: 10.1186/s12931-019-1025-y.

4.

Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study.

von Siemens SM, Jörres RA, Behr J, Alter P, Lutter J, Lucke T, Söhler S, Welte T, Watz H, Vogelmeier CF, Trudzinski F, Rief W, Herbig B, Kahnert K; COSYCONET study group.

Respir Res. 2019 Feb 11;20(1):30. doi: 10.1186/s12931-019-0997-y.

5.

Lung function and oral health in adolescents.

Heinrich J, Thiering E, Jörres RA, Schulz H, Kühnisch J, Standl M.

Eur Respir J. 2019 Mar 7;53(3). pii: 1801951. doi: 10.1183/13993003.01951-2018. Print 2019 Mar. No abstract available.

PMID:
30487207
6.

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort.

Greulich T, Mager S, Lucke T, Koczulla AR, Bals R, Fähndrich S, Jörres RA, Alter P, Kirsten A, Vogelmeier CF, Watz H.

Int J Chron Obstruct Pulmon Dis. 2018 Sep 28;13:2999-3002. doi: 10.2147/COPD.S165909. eCollection 2018. No abstract available.

7.

Medical Treatment of COPD.

Graf J, Jörres RA, Lucke T, Nowak D, Vogelmeier CF, Ficker JH.

Dtsch Arztebl Int. 2018 Sep 14;155(37):599-605. doi: 10.3238/arztebl.2018.0599.

8.

Acute effects of hypertonic saline inhalation on nitric oxide pulmonary diffusing capacity in healthy adults.

Karrasch S, Radtke T, Simon M, Kronseder A, Dressel H, Jörres RA, Ochmann U.

Respir Physiol Neurobiol. 2018 Dec;258:40-46. doi: 10.1016/j.resp.2018.09.007. Epub 2018 Sep 24.

PMID:
30261306
9.

Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation.

Winkler A, Kahnert K, Behr J, Neurohr C, Kneidinger N, Hatz R, Dressel H, Radtke T, Jörres RA.

Respir Res. 2018 Sep 10;19(1):171. doi: 10.1186/s12931-018-0881-1.

10.

Influence of body mass on predicted values of static hyperinflation in COPD.

Alter P, Rabe KF, Schulz H, Vogelmeier CF, Jörres RA.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 23;13:2551-2555. doi: 10.2147/COPD.S164096. eCollection 2018.

11.

Concomitance of cardiovascular and pulmonary disorders: mutual bystanders or causal interactions?

Alter P, Jörres RA.

Kardiol Pol. 2018;76(7):1027-1028. doi: 10.5603/KP.2018.0132. No abstract available.

12.

Genome-wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development.

Keller A, Fehlmann T, Ludwig N, Kahraman M, Laufer T, Backes C, Vogelmeier C, Diener C, Biertz F, Herr C, Jörres RA, Lenhof HP, Meese E, Bals R; COSYCONET Study Group.

Genomics Proteomics Bioinformatics. 2018 Jun;16(3):162-171. doi: 10.1016/j.gpb.2018.06.001. Epub 2018 Jul 5.

13.

Design and application of an MR reference phantom for multicentre lung imaging trials.

Triphan SMF, Biederer J, Burmester K, Fellhauer I, Vogelmeier CF, Jörres RA, Kauczor HU, Heußel CP, Wielpütz MO, Jobst BJ.

PLoS One. 2018 Jul 5;13(7):e0199148. doi: 10.1371/journal.pone.0199148. eCollection 2018.

14.

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach.

Kahnert K, Alter P, Welte T, Huber RM, Behr J, Biertz F, Watz H, Bals R, Vogelmeier CF, Jörres RA.

Respir Res. 2018 Jun 4;19(1):110. doi: 10.1186/s12931-018-0815-y.

15.

Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans.

Kahnert K, Jobst B, Biertz F, Biederer J, Watz H, Huber RM, Behr J, Grenier PA, Alter P, Vogelmeier CF, Kauczor HU, Jörres RA.

Chron Respir Dis. 2019 Jan-Dec;16:1479972318775423. doi: 10.1177/1479972318775423. Epub 2018 May 9.

16.

Left ventricular volume and wall stress are linked to lung function impairment in COPD.

Alter P, Jörres RA, Watz H, Welte T, Gläser S, Schulz H, Bals R, Karch A, Wouters EFM, Vestbo J, Young D, Vogelmeier CF.

Int J Cardiol. 2018 Jun 15;261:172-178. doi: 10.1016/j.ijcard.2018.02.074.

PMID:
29657040
17.

Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling.

Alter P, Watz H, Kahnert K, Pfeifer M, Randerath WJ, Andreas S, Waschki B, Kleibrink BE, Welte T, Bals R, Schulz H, Biertz F, Young D, Vogelmeier CF, Jörres RA.

Respir Med. 2018 Apr;137:14-22. doi: 10.1016/j.rmed.2018.02.011. Epub 2018 Feb 19.

PMID:
29605197
18.

Acute health effects of desktop 3D printing (fused deposition modeling) using acrylonitrile butadiene styrene and polylactic acid materials: An experimental exposure study in human volunteers.

Gümperlein I, Fischer E, Dietrich-Gümperlein G, Karrasch S, Nowak D, Jörres RA, Schierl R.

Indoor Air. 2018 Jul;28(4):611-623. doi: 10.1111/ina.12458. Epub 2018 Mar 25.

PMID:
29500848
19.

Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPD.

Graf J, Lucke T, Herrera R, Watz H, Holle R, Vogelmeier C, Ficker JH, Jörres RA.

Pulm Pharmacol Ther. 2018 Apr;49:123-129. doi: 10.1016/j.pupt.2018.01.011. Epub 2018 Feb 5.

PMID:
29421666
20.

The revised GOLD 2017 COPD categorization in relation to comorbidities.

Kahnert K, Alter P, Young D, Lucke T, Heinrich J, Huber RM, Behr J, Wacker M, Biertz F, Watz H, Bals R, Welte T, Wirtz H, Herth F, Vestbo J, Wouters EF, Vogelmeier CF, Jörres RA.

Respir Med. 2018 Jan;134:79-85. doi: 10.1016/j.rmed.2017.12.003. Epub 2017 Dec 5.

21.

Heterogeneous pattern of differences in respiratory parameters between elderly with either good or poor FEV1.

Karrasch S, Behr J, Huber RM, Nowak D, Peters A, Peters S, Holle R, Jörres RA, Schulz H; KORA Study Group.

BMC Pulm Med. 2018 Feb 6;18(1):27. doi: 10.1186/s12890-018-0582-z.

22.

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort.

Wacker ME, Kitzing K, Jörres RA, Leidl R, Schulz H, Karrasch S, Karch A, Koch A, Vogelmeier CF, Holle R.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 4;12:3437-3448. doi: 10.2147/COPD.S141852. eCollection 2017.

23.

Ventilation inhomogeneity in obstructive lung diseases measured by electrical impedance tomography: a simulation study.

Schullcke B, Krueger-Ziolek S, Gong B, Jörres RA, Mueller-Lisse U, Moeller K.

J Clin Monit Comput. 2018 Aug;32(4):753-761. doi: 10.1007/s10877-017-0069-0. Epub 2017 Oct 10.

PMID:
29019006
24.

Psychological and cognitive effects of laser printer emissions: A controlled exposure study.

Herbig B, Jörres RA, Schierl R, Simon M, Langner J, Seeger S, Nowak D, Karrasch S.

Indoor Air. 2018 Jan;28(1):112-124. doi: 10.1111/ina.12429. Epub 2017 Oct 28.

PMID:
28960517
25.

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency.

Fähndrich S, Biertz F, Karch A, Kleibrink B, Koch A, Teschler H, Welte T, Kauczor HU, Janciauskiene S, Jörres RA, Greulich T, Vogelmeier CF, Bals R; COSYCONET investigators.

Respir Res. 2017 Sep 15;18(1):171. doi: 10.1186/s12931-017-0655-1.

26.

Associations Between Age, Psychosocial Work Conditions, Occupational Well-Being, and Telomere Length in Geriatric Care Professionals: A Mixed-Methods Study.

Chmelar C, Jörres RA, Kronseder A, Müller A, Nowak D, Weigl M.

J Occup Environ Med. 2017 Oct;59(10):949-955. doi: 10.1097/JOM.0000000000001102.

PMID:
28697059
27.

Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.

Kahnert K, Lucke T, Huber RM, Behr J, Biertz F, Vogt A, Watz H, Alter P, Fähndrich S, Bals R, Holle R, Karrasch S, Söhler S, Wacker M, Ficker JH, Parhofer KG, Vogelmeier C, Jörres RA; COSYCONET consortium.

PLoS One. 2017 May 15;12(5):e0177501. doi: 10.1371/journal.pone.0177501. eCollection 2017.

28.

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.

Karl FM, Holle R, Bals R, Greulich T, Jörres RA, Karch A, Koch A, Karrasch S, Leidl R, Schulz H, Vogelmeier C, Wacker ME; COSYCONET Study Group.

Respir Res. 2017 Apr 17;18(1):60. doi: 10.1186/s12931-017-0543-8.

29.

Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.

Kahnert K, Lucke T, Biertz F, Lechner A, Watz H, Alter P, Bals R, Behr J, Holle R, Huber RM, Karrasch S, Stubbe B, Wacker M, Söhler S, Wouters EF, Vogelmeier C, Jörres RA; COSYCONET study group.

Respir Res. 2017 Jan 13;18(1):14. doi: 10.1186/s12931-016-0499-0.

30.

Health effects of laser printer emissions: a controlled exposure study.

Karrasch S, Simon M, Herbig B, Langner J, Seeger S, Kronseder A, Peters S, Dietrich-Gümperlein G, Schierl R, Nowak D, Jörres RA.

Indoor Air. 2017 Jul;27(4):753-765. doi: 10.1111/ina.12366. Epub 2017 Feb 2.

PMID:
28054389
31.

[Respiratory and allergic diseases of children : Temporal trends, urban-rural differences, and in association with environmental tobacco smoke exposure].

Gürlich K, Herr C, Hendrowarsito L, Weber A, Nennstiel-Ratzel U, Wildner M, Liebl B, Bolte G, Jörres RA, Kolb S; GME-Studiengruppe.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Dec;59(12):1566-1576. German.

PMID:
27796430
32.

Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies - A Novel Stepwise Approach by Evaluation of Medication.

Lucke T, Herrera R, Wacker M, Holle R, Biertz F, Nowak D, Huber RM, Söhler S, Vogelmeier C, Ficker JH, Mückter H, Jörres RA; COSYCONET-Consortium.

PLoS One. 2016 Oct 28;11(10):e0163408. doi: 10.1371/journal.pone.0163408. eCollection 2016.

33.

Hydrogen peroxide in exhaled air: a source of error, a paradox and its resolution.

Peters S, Kronseder A, Karrasch S, Neff PA, Haaks M, Koczulla AR, Reinhold P, Nowak D, Jörres RA.

ERJ Open Res. 2016 Jun 17;2(2). pii: 00052-2015. eCollection 2016 Apr.

34.

Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study.

Houben-Wilke S, Jörres RA, Bals R, Franssen FM, Gläser S, Holle R, Karch A, Koch A, Magnussen H, Obst A, Schulz H, Spruit MA, Wacker ME, Welte T, Wouters EF, Vogelmeier C, Watz H.

Am J Respir Crit Care Med. 2017 Jan 15;195(2):189-197. doi: 10.1164/rccm.201602-0354OC.

PMID:
27532739
35.

Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.

Wacker ME, Jörres RA, Karch A, Koch A, Heinrich J, Karrasch S, Schulz H, Peters A, Gläser S, Ewert R, Baumeister SE, Vogelmeier C, Leidl R, Holle R; COSYCONET study group.

Respir Res. 2016 Jul 12;17(1):81. doi: 10.1186/s12931-016-0401-0.

36.

Accuracy of FENO for diagnosing asthma: a systematic review.

Karrasch S, Linde K, Rücker G, Sommer H, Karsch-Völk M, Kleijnen J, Jörres RA, Schneider A.

Thorax. 2017 Feb;72(2):109-116. doi: 10.1136/thoraxjnl-2016-208704. Epub 2016 Jul 7. Review.

PMID:
27388487
37.

Lung function and associations with multiple dimensions of dental health: a prospective observational cross-sectional study.

Henke C, Budweiser S, Jörres RA.

BMC Res Notes. 2016 May 17;9:274. doi: 10.1186/s13104-016-2079-2.

38.

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.

Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, Koch A, Schulz H, Watz H, Leidl R, Vogelmeier C, Holle R; COSYCONET-Consortium.

BMC Pulm Med. 2016 May 10;16(1):70. doi: 10.1186/s12890-016-0238-9.

39.

Biological effects of inhaled nitrogen dioxide in healthy human subjects.

Brand P, Bertram J, Chaker A, Jörres RA, Kronseder A, Kraus T, Gube M.

Int Arch Occup Environ Health. 2016 Aug;89(6):1017-24. doi: 10.1007/s00420-016-1139-1. Epub 2016 May 7.

PMID:
27155612
40.

The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline.

Karch A, Vogelmeier C, Welte T, Bals R, Kauczor HU, Biederer J, Heinrich J, Schulz H, Gläser S, Holle R, Watz H, Korn S, Adaskina N, Biertz F, Vogel C, Vestbo J, Wouters EF, Rabe KF, Söhler S, Koch A, Jörres RA; COSYCONET Study Group.

Respir Med. 2016 May;114:27-37. doi: 10.1016/j.rmed.2016.03.008. Epub 2016 Mar 11.

41.

Correction: Comparison of Two Devices and Two Breathing Patterns for Exhaled Breath Condensate Sampling.

Hüttmann EM, Greulich T, Koepke J, Nell C, Hattesohl A, Schmid S, Noeske S, Herr C, John G, Jörres RA, Müller B, Vogelmeier C, Koczulla AR.

PLoS One. 2016 Mar 28;11(3):e0152620. doi: 10.1371/journal.pone.0152620. eCollection 2016. No abstract available.

42.

Mental health, serum biomarkers and survival in severe COPD: a pilot study.

Zilz C, Blaas SH, Pfeifer M, Jörres RA, Budweiser S.

Multidiscip Respir Med. 2016 Jan 18;11:3. doi: 10.1186/s40248-016-0041-8. eCollection 2015.

43.

Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study.

Wacker ME, Jörres RA, Schulz H, Heinrich J, Karrasch S, Karch A, Koch A, Peters A, Leidl R, Vogelmeier C, Holle R; COSYCONET-Consortium.

Respir Med. 2016 Feb;111:39-46. doi: 10.1016/j.rmed.2015.12.001. Epub 2015 Dec 10.

44.

Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma.

Schneider A, Wagenpfeil G, Jörres RA, Wagenpfeil S.

BMJ Open. 2015 Nov 24;5(11):e009676. doi: 10.1136/bmjopen-2015-009676.

45.

Whole-Body Plethysmography in Suspected Asthma: A Prospective Study of Its Added Diagnostic Value in 302 Patients.

Schneider A, Schwarzbach J, Faderl B, Hautmann H, Jörres RA.

Dtsch Arztebl Int. 2015 Jun 12;112(24):405-11. doi: 10.3238/arztebl.2015.0405.

46.

[Standardization of spirometry: 2015 update. Published by German Atemwegsliga, German Respiratory Society and German Society of Occupational and Environmental Medicine].

Criée CP, Baur X, Berdel D, Bösch D, Gappa M, Haidl P, Husemann K, Jörres RA, Kabitz HJ, Kardos P, Köhler D, Magnussen H, Merget R, Mitfessel H, Nowak D, Ochmann U, Schürmann W, Smith HJ, Sorichter S, Voshaar T, Worth H.

Pneumologie. 2015 Mar;69(3):147-64. doi: 10.1055/s-0034-1391345. Epub 2015 Mar 6. German.

47.

E-cigarettes--prevention, pulmonary health, and addiction.

Nowak D, Jörres RA, Rüther T.

Dtsch Arztebl Int. 2014 May 16;111(20):349-55. doi: 10.3238/arztebl.2014.0349. Review.

48.

Response to letter regarding article, "use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers".

Schober W, Jörres RA, Fromme H.

Int J Hyg Environ Health. 2014 Jul;217(6):707-8. doi: 10.1016/j.ijheh.2014.02.003. Epub 2014 Feb 27. No abstract available.

PMID:
24641997
49.

Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers.

Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heitmann D, Schettgen T, Jörres RA, Fromme H.

Int J Hyg Environ Health. 2014 Jul;217(6):628-37. doi: 10.1016/j.ijheh.2013.11.003. Epub 2013 Dec 6.

PMID:
24373737
50.

The clinical significance of anaemia and disturbed iron homeostasis in chronic respiratory failure.

Schneckenpointner R, Jörres RA, Meidenbauer N, Kollert F, Pfeifer M, Budweiser S.

Int J Clin Pract. 2014 Jan;68(1):130-8. doi: 10.1111/ijcp.12216.

PMID:
24341307

Supplemental Content

Loading ...
Support Center